FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21973211000001102: Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73029601000001110 Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73029701000001117 Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Is a Mirabegron 50mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Mirabegron false Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Betmiga 50mg modified-release tablets (Astellas Pharma Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Mirabegron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start